The forecast for the import of blood-grouping reagents to the UK indicates a steady increase from 120.51 thousand kilograms in 2024 to 122.86 thousand kilograms by 2028. This represents a modest year-on-year growth of around 0.8% to 0.5% annually. Assuming the same amount for 2023, the CAGR across 2024-2028 remains subtly positive, reflecting an incremental demand for these medical products.
Future trends to watch include:
- Technological advancements in blood grouping technologies.
- Regulatory changes affecting the import of medical reagents.
- Shifts in healthcare policies and increasing focus on personalized medicine.
- Potential disruptions in supply chain logistics due to geopolitical events.
